Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Return on Capital Employed (2016 - 2026)

Conmed filings provide 16 years of Return on Capital Employed readings, the most recent being 5.53% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 345.0% to 5.53% in Q1 2026 year-over-year; TTM through Mar 2026 was 5.53%, a 345.0% decrease, with the full-year FY2025 number at 5.13%, down 476.0% from a year prior.
  • Return on Capital Employed hit 5.53% in Q1 2026 for Conmed, up from 5.11% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 9.85% in Q4 2024 to a low of 3.03% in Q1 2023.
  • Median Return on Capital Employed over the past 5 years was 6.02% (2023), compared with a mean of 6.3%.
  • Biggest five-year swings in Return on Capital Employed: surged 625bps in 2024 and later crashed -475bps in 2025.
  • Conmed's Return on Capital Employed stood at 3.51% in 2022, then skyrocketed by 72bps to 6.02% in 2023, then soared by 64bps to 9.85% in 2024, then tumbled by -48bps to 5.11% in 2025, then increased by 8bps to 5.53% in 2026.
  • The last three reported values for Return on Capital Employed were 5.53% (Q1 2026), 5.11% (Q4 2025), and 5.89% (Q3 2025) per Business Quant data.